Metformin hydrochloride - Diabetes Mellitus
You are here : Home > Formulary Search > Metformin hydrochloride - Diabetes Mellitus
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Green
Formulations :
- Modified release tablets
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Preferred
NOTE: 1g oridnary tablets are disproportionately expensive in primary care. 1g modified release tablets are recommended.
Status 2
Green (see narrative)
Formulations :
- Oral solution
- Powder
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Oral solution should be reserved for patients with enteral feeding tubes or those unable to swallow tablets.
Sachets of powder for oral solution are preferred in patients with swallowing difficulties in primary care.
Documentation
Guidelines (Local)
PAD Profile
ChemicalSubstance :
Metformin hydrochloride
Indication :
Diabetes Mellitus
Group Name :
Keywords :
Renal Impairment, Kidney Disease, metformin dose titration, metformin intolerance, metformin side effects
Brand Names Include :
Glucophage SR, Bolamyn SR, Diagemet XL, Glucient SR, Metabet SR, Sukkarto SR
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
5
Traffic Light Entries :
2
Other Indications
Below are listed other indications that Metformin hydrochloride is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Diabetes Mellitus.
- Acarbose
- Alogliptin
- Alogliptin/metformin
- Biphasic Insulin Aspart - Novmix 30
- Biphasic Isophane Insulin - Humulin M3
- Biphasic Lispro Insulin - Humalog Mix 25
- Biphasic Lispro Insulin - Humalog Mix 50
- Canagliflozin/metformin
- Dapagliflozin
- Dapagliflozin/metformin
- Diazoxide
- Dulaglutide
- Empagliflozin
- Empagliflozin/metformin
- Ertugliflozin
- Exenatide
- Glibenclamide
- Gliclazide
- Glimepiride
- Glipizide
- Glucose
- Glyxambi (Linagliptin/empagliflozin)
- Insulin Aspart - Fiasp
- Insulin aspart - NovoRapid
- Insulin Aspart - Trurapi
- Insulin degludec
- Insulin degludec with liraglutide
- Insulin detemir
- Insulin glargine - Abasaglar
- Insulin glargine - Lantus
- Insulin glargine - Semglee
- Insulin Glargine - Toujeo
- Insulin glulisine - Apidra
- Insulin Lispro - Admelog
- Insulin Lispro - Humalog
- Insulin Lispro - Lyumjev
- Insulin pump - Type 1 diabetes
- Isophane (neutral insulin) - hypurin porcine 30/70
- Isophane Insulin - Humulin I
- Isophane Insulin - Hypurin Porcine Isophane
- Isophane Insulin - Insulatard
- Linagliptin
- Linagliptin/metformin
- Liraglutide
- Metformin hydrochloride/pioglitazone
- Metformin hydrochloride/sitagliptin
- Metformin hydrochloride/vildagliptin
- Pioglitazone hydrochloride
- Repaglinide
- Saxagliptin
- Saxagliptin/dapagliflozin
- Semaglutide
- Sitagliptin
- Soluble insulin - Hypurin porcine neutral
- Soluble insulin - Actrapid
- Soluble insulin - Humulin S
- Sotagliflozin
- Suliqua (Insulin glargine/lixisenatide)
- Tirzepatide
- Tolbutamide
- Vildagliptin
Committee Recommendations (1)
Metformin should be considered as the drug of first choice particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control.
Appropriate dose titration and patient education will reduce the likelihood of metformin intolerance - see dose titration guide below.
Advice on use of metformin in renal impairment was previously considered by the PCN in June 2015 (Please see policy statement PCN163-2015) for further information
Appropriate dose titration and patient education will reduce the likelihood of metformin intolerance - see dose titration guide below.
Advice on use of metformin in renal impairment was previously considered by the PCN in June 2015 (Please see policy statement PCN163-2015) for further information